Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W I Bensinger

Showing results (71-80 of 152) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|March 1, 1994
Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantationM A Neubauer, M C Benyunes, J A Thompson, et al.
Bone Marrow Transplantation|June 1, 1996
Factors influencing collection of peripheral blood stem cells in patients with multiple myelomaT Demirer, C D Buckner, T Gooley, et al.
Bone Marrow Transplantation|May 1, 1996
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancerT Demirer, C D Buckner, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factorT Demirer, C D Buckner, B Storer, et al.
Journal of Clinical Apheresis|January 1, 1987
Use of arteriovenous shunts and right atrial catheters for daily granulocyte collectionB M Williams, J E Sanders, R A Clift, et al.
British Journal of Haematology|August 1, 1994
Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantationW I Bensinger, K Longin, F Appelbaum, et al.
Blood|July 15, 1996
Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysisP A McSweeney, D A Wells, K E Shults, et al.
Blood|October 1, 1996
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcomeW I Bensinger, C D Buckner, C Anasetti, et al.
Lancet (London, England)|April 22, 1995
Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donorL W Kwak, D D Taub, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patientsJ T Slattery, T F Kalhorn, G B McDonald, et al.
Pageof 16

Showing results (71-80 of 152) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|March 1, 1994
Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantationM A Neubauer, M C Benyunes, J A Thompson, et al.
Bone Marrow Transplantation|June 1, 1996
Factors influencing collection of peripheral blood stem cells in patients with multiple myelomaT Demirer, C D Buckner, T Gooley, et al.
Bone Marrow Transplantation|May 1, 1996
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancerT Demirer, C D Buckner, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factorT Demirer, C D Buckner, B Storer, et al.
Journal of Clinical Apheresis|January 1, 1987
Use of arteriovenous shunts and right atrial catheters for daily granulocyte collectionB M Williams, J E Sanders, R A Clift, et al.
British Journal of Haematology|August 1, 1994
Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantationW I Bensinger, K Longin, F Appelbaum, et al.
Blood|July 15, 1996
Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysisP A McSweeney, D A Wells, K E Shults, et al.
Blood|October 1, 1996
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcomeW I Bensinger, C D Buckner, C Anasetti, et al.
Lancet (London, England)|April 22, 1995
Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donorL W Kwak, D D Taub, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patientsJ T Slattery, T F Kalhorn, G B McDonald, et al.
Pageof 16